GLNMX | RSLDX | GLNMX / RSLDX | |
Total Expense Ratio | 1.10 | 0.80 | 138% |
Annual Report Gross Expense Ratio | 1.56 | 0.80 | 195% |
Fund Existence | 14 years | 10 years | - |
Gain YTD | 11.452 | 9.684 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 76.8M | 79.8B | 0% |
Annual Yield % from dividends | 0.56 | 0.81 | 70% |
Returns for 1 year | 12.53 | 10.07 | 125% |
Returns for 3 years | 33.66 | 33.39 | 101% |
Returns for 5 years | 23.14 | 20.95 | 110% |
Returns for 10 years | 66.08 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GMVCX | 15.79 | 0.14 | +0.89% |
Goldman Sachs Small/Mid Cap Equity C | |||
SBQIX | 14.98 | 0.13 | +0.88% |
AmericaFirst Alpha Trends Factor Class I | |||
FSSZX | 38.56 | 0.32 | +0.84% |
Fidelity Advisor Stock Selector Sm Cp Z | |||
PJHRX | 30.45 | 0.15 | +0.50% |
PGIM Jennison Health Sciences R | |||
FGNCX | 12.59 | -0.01 | -0.08% |
Nuveen Global Infrastructure C |